Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA193461,10.1016/j.celrep.2023.113564,Cell Rep,38100350,https://pubmed.ncbi.nlm.nih.gov/38100350,Heterogeneity and transcriptional drivers of triple-negative breast cancer,2023,"Triple-negative Breast Cancer, Tumor Heterogeneity, Cp: Cancer","Bojana Jovanović, Daniel Temko, Laura E Stevens, Marco Seehawer, Anne Fassl, Katherine Murphy, Jayati Anand, Kodie Garza, Anushree Gulvady, Xintao Qiu, Nicholas W Harper, Veerle W Daniels, Huang Xiao-Yun, Jennifer Y Ge, Maša Alečković, Jason Pyrdol, Kunihiko Hinohara, Shawn B Egri, Malvina Papanastasiou, Raga Vadhi, Alba Font-Tello, Robert Witwicki, Guillermo Peluffo, Anne Trinh, Shaokun Shu, Bene(Read more on Pubmed)","Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity, we defined transcriptional, epigenetic, and metabolic subtypes and subtype-driving super-enhancers and transcription factors by combining functional and molecular profiling with computational analyses. Single-cell RNA sequencing revealed relative homogeneity of the ma(Read more on Pubmed)","ChIP-Seq, RNA Sequencing, Mass Spectrometry, Mass Cytometry, Immunofluorescent Staining Method, Immunohistochemistry Staining Method, Single Cell RNA-Sequencing",Triple-Negative Breast Carcinoma       ,Not Applicable,GSE202776,Open Access,38100350,727da2cf-28ad-4520-a0f6-4b0f917ed65c,syn52499989
